Researchers presenting at the EADV Congress found a clear link, but about half of users had nail issues before treatment. They advise talking to a doctor rather than stopping the drug.
Recap by typeshit. Full story at AOL.com.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A short local news segment on a study that researchers say points to GLP-1 drugs possibly slowing the aging process. Details are thin, so check the source.
9:11
A short clip weighing the approved tirzepatide against retatrutide, which is still in trials, for people over 50.
Loading…